MediPharm Signs Customer Contracts Ahead of TSX-V Listing
MMJ's CEO Jason Conroy said that "We are delighted to see the momentum building for MediPharm ahead of its listing on the TSX-V."
MMJ owns approximately 6.9% of MediPharm.
To view the news releases, please visit:
About MMJ PhytoTech Ltd
MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/
MMJ PhytoTech Ltd